Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer

Ovarian cancer is the deadliest of all gynecologic cancers. Despite success with initial chemotherapy, the majority of patients relapse with an incurable disease. Development of chemotherapy resistance is a major factor for poor long-term survival in ovarian cancer. The biological effects of estroge...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Zhou, Mei, Nair, Binoj C., Kost, Edward, Tekmal, Rajeshwar Rao, Li, Rong, Rao, Manjeet K., Curiel, Tyler, Vadlamudi, Ratna K., Sareddy, Gangadhara R.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564823/
https://ncbi.nlm.nih.gov/pubmed/28654894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18442
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares